These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 10336495)
41. Identification of the CREB-binding protein/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor alpha coregulator. Tien ES; Davis JW; Vanden Heuvel JP J Biol Chem; 2004 Jun; 279(23):24053-63. PubMed ID: 15051727 [TBL] [Abstract][Full Text] [Related]
42. A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator-activated receptor DNA binding. Hsu MH; Palmer CN; Song W; Griffin KJ; Johnson EF J Biol Chem; 1998 Oct; 273(43):27988-97. PubMed ID: 9774413 [TBL] [Abstract][Full Text] [Related]
43. Different ways to regulate the PPARalpha stability. Blanquart C; Mansouri R; Fruchart JC; Staels B; Glineur C Biochem Biophys Res Commun; 2004 Jun; 319(2):663-70. PubMed ID: 15178457 [TBL] [Abstract][Full Text] [Related]
44. Peroxisome proliferator-activated receptor alpha activates transcription of the brown fat uncoupling protein-1 gene. A link between regulation of the thermogenic and lipid oxidation pathways in the brown fat cell. Barbera MJ; Schluter A; Pedraza N; Iglesias R; Villarroya F; Giralt M J Biol Chem; 2001 Jan; 276(2):1486-93. PubMed ID: 11050084 [TBL] [Abstract][Full Text] [Related]
45. A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma. Wang Y; Porter WW; Suh N; Honda T; Gribble GW; Leesnitzer LM; Plunket KD; Mangelsdorf DJ; Blanchard SG; Willson TM; Sporn MB Mol Endocrinol; 2000 Oct; 14(10):1550-6. PubMed ID: 11043571 [TBL] [Abstract][Full Text] [Related]
46. Stabilization of peroxisome proliferator-activated receptor alpha by the ligand. Hirotani M; Tsukamoto T; Bourdeaux J; Sadano H; Osumi T Biochem Biophys Res Commun; 2001 Oct; 288(1):106-10. PubMed ID: 11594759 [TBL] [Abstract][Full Text] [Related]
47. Selective partial agonism of liver X receptor alpha is related to differential corepressor recruitment. Phelan CA; Weaver JM; Steger DJ; Joshi S; Maslany JT; Collins JL; Zuercher WJ; Willson TM; Walker M; Jaye M; Lazar MA Mol Endocrinol; 2008 Oct; 22(10):2241-9. PubMed ID: 18669643 [TBL] [Abstract][Full Text] [Related]
48. Alterations of PPARalpha and its coactivator PGC-1 in cisplatin-induced acute renal failure. Portilla D; Dai G; McClure T; Bates L; Kurten R; Megyesi J; Price P; Li S Kidney Int; 2002 Oct; 62(4):1208-18. PubMed ID: 12234291 [TBL] [Abstract][Full Text] [Related]
49. The murine and human cholesterol 7alpha-hydroxylase gene promoters are differentially responsive to regulation by fatty acids mediated via peroxisome proliferator-activated receptor alpha. Cheema SK; Agellon LB J Biol Chem; 2000 Apr; 275(17):12530-6. PubMed ID: 10777541 [TBL] [Abstract][Full Text] [Related]
51. Modulation of the expression of peroxisome proliferator-activated receptor-dependent genes through disproportional expression of two subtypes in the small intestine. Mochizuki K; Suruga K; Kitagawa M; Takase S; Goda T Arch Biochem Biophys; 2001 May; 389(1):41-8. PubMed ID: 11370670 [TBL] [Abstract][Full Text] [Related]
52. The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling. Shi Y; Hon M; Evans RM Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2613-8. PubMed ID: 11867749 [TBL] [Abstract][Full Text] [Related]
54. A dominant negative human peroxisome proliferator-activated receptor (PPAR){alpha} is a constitutive transcriptional corepressor and inhibits signaling through all PPAR isoforms. Semple RK; Meirhaeghe A; Vidal-Puig AJ; Schwabe JW; Wiggins D; Gibbons GF; Gurnell M; Chatterjee VK; O'Rahilly S Endocrinology; 2005 Apr; 146(4):1871-82. PubMed ID: 15661858 [TBL] [Abstract][Full Text] [Related]
55. Molecular basis of non-responsiveness to peroxisome proliferators: the guinea-pig PPARalpha is functional and mediates peroxisome proliferator-induced hypolipidaemia. Bell AR; Savory R; Horley NJ; Choudhury AI; Dickins M; Gray TJ; Salter AM; Bell DR Biochem J; 1998 Jun; 332 ( Pt 3)(Pt 3):689-93. PubMed ID: 9620871 [TBL] [Abstract][Full Text] [Related]
56. Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor. Cheng S; Brzostek S; Lee SR; Hollenberg AN; Balk SP Mol Endocrinol; 2002 Jul; 16(7):1492-501. PubMed ID: 12089345 [TBL] [Abstract][Full Text] [Related]
57. Novel receptor interaction and repression domains in the orphan receptor SHP. Seol W; Chung M; Moore DD Mol Cell Biol; 1997 Dec; 17(12):7126-31. PubMed ID: 9372944 [TBL] [Abstract][Full Text] [Related]
58. Activation of the prolactin gene by peroxisome proliferator-activated receptor-alpha appears to be DNA binding-independent. Tolón RM; Castillo AI; Aranda A J Biol Chem; 1998 Oct; 273(41):26652-61. PubMed ID: 9756906 [TBL] [Abstract][Full Text] [Related]
59. Ligand-independent coregulator recruitment by the triply activatable OR1/retinoid X receptor-alpha nuclear receptor heterodimer. Wiebel FF; Steffensen KR; Treuter E; Feltkamp D; Gustafsson JA Mol Endocrinol; 1999 Jul; 13(7):1105-18. PubMed ID: 10406462 [TBL] [Abstract][Full Text] [Related]
60. Hypoxia inhibits the peroxisome proliferator-activated receptor alpha/retinoid X receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation. Huss JM; Levy FH; Kelly DP J Biol Chem; 2001 Jul; 276(29):27605-12. PubMed ID: 11371554 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]